MUTANT PROTEINS, HIGH POTENCY INHIBITORY ANTIBODIES AND FIMCH CRYSTAL STRUCTURE

Details for Australian Patent Application No. 2001297896 (hide)

Owner MEDIMMUNE, INC.

Inventors LANGERMANN, Solomon, R.; HULTGREN, Scott, J.; HUNG, Chia-Suei; BOUCKAERT, Julie

Pub. Number AU-A-2001297896

PCT Number PCT/US01/47994

PCT Pub. Number WO2002/102974

Priority 60/254,353 08.12.00 US; 60/301,878 29.06.01 US

Filing date 10 December 2001

Wipo publication date 2 January 2003

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 60/254,353 08.12.00 US; 60/301,878 29.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2001297896

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001297897-Method and system for processing upstream packets of an optical network

2001297895-DIAGNOSTICS AND THERAPEUTICS FOR GLAUCOMA RETINAL DEGENERATIVE DISEASES AND CARDIOVASCULAR DISEASES BASED ON NOVEL NUCLEIC ACID AND PROTEIN FORMS OF MYOCILIN (MYOC)